Evidence map›Paper›PMID 36919088›Full record

ArticleHeliyon2023

Epidemiology of respiratory tract infections using multiplex PCR in a Japanese acute care hospital during the COVID19 pandemic.

Daisuke Kitagawa, Taito Kitano, Madoka Furumori, Soma Suzuki, Yui Shintani, Yuki Suzuki, Akiyo Nakano, Ryuichi Nakano, Atsuko Nishiyama, Sayaka Yoshida and 3 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Daisuke KitagawaDepartment of Laboratory Medicine, Nara Prefecture General Medical Center, Japan.
Taito KitanoJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Madoka FurumoriDepartment of Laboratory Medicine, Nara Prefecture General Medical Center, Japan.
Soma SuzukiDepartment of Laboratory Medicine, Nara Prefecture General Medical Center, Japan.
Yui ShintaniDepartment of Laboratory Medicine, Nara Prefecture General Medical Center, Japan.
Yuki SuzukiDepartment of Microbiology and Infectious Diseases, Nara Medical University, Japan.
Akiyo NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Japan.
Ryuichi NakanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Japan.
Atsuko NishiyamaDepartment of Pediatrics, Nara Prefecture General Medical Center, Japan.
Sayaka YoshidaDepartment of Pediatrics, Nara Prefecture General Medical Center, Japan.
Hisakazu YanoDepartment of Microbiology and Infectious Diseases, Nara Medical University, Japan.
Koichi MaedaDepartment of Infectious Diseases, Nara Prefecture General Medical Center, Japan.
Fumihiko NakamuraDepartment of Laboratory Medicine, Nara Prefecture General Medical Center, Japan.
Nara Prefecture General Medical CenterNara Medical University · JPJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: We aimed to investigate the epidemiology of respiratory infections by season and age during the COVID-19 pandemic in a Japanese acute care hospital using multiplex PCR testing. Methods: We detected 21 pathogens in specimens from outpatients with respiratory symptoms at the Nara Prefecture General Medical Center using the multiplex PCR-based FilmArray Respiratory Panel 2.1 (bioMérieux). Results: Of the 3177 cases, 1215 (38.2%) were infected with at least one causative virus, and 1641 viruses were detected. The most common viruses detected were human rhinovirus/enterovirus (n = 655) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (n = 264). Additionally, 321 (10.1%) of these cases were infected with two or more overlapping viruses. There were 23 cases of co-infection with SARS-CoV-2 and other viruses. In the winter months from December 2020 to March 2021, the number of detected viruses was relatively low, followed by the surge of human rhinovirus/enterovirus, respiratory syncytial virus (RSV), and parainfluenza type 3 in the spring and summer of 2021. While the number of human rhinovirus/entero-virus remained relatively high after the 2021 summer, the number of other viruses detected since September 2021 was low. After December 2021, the number of SARS-CoV-2 increased rapidly. Conclusions: Continuous monitoring of the epidemiology of respiratory infection is important to understand the prolonged impact of the COVID-19 pandemic.

Indexed as

COVID19EpidemiologyFilmArray respiratory panel 2.1Multiplex PCRRespiratory infection virusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Identifiers

PMID36919088
PMCPMC10007720
OpenAlexW4323928812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.